Claribax 500 mg FC tablets
PDF Leaflet Revision Date: 10 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various bacterial infections and H. pylori eradication.
Dosage (summary)
Adults: 250 mg twice daily, can increase to 500 mg twice daily for severe infections.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not advised during pregnancy; excreted in breast milk, avoid during breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Warfarin
- Statins (lovastatin, simvastatin)
- Colchicine
Contraindications
- Hypersensitivity to clarithromycin
- Concomitant use with ergot alkaloids
- QT prolongation history
Common side effects
- Diarrhoea
- Nausea
- Abdominal pain
- Taste perversion
Counselling Points
- Take with or without food
- Monitor for signs of liver dysfunction
- Use alternative contraception during treatment
Serious warnings
- Risk of QT prolongation
- Severe hepatic dysfunction
- Pseudomembranous colitis
Important Disclaimer
The Claribax 500 mg FC tablets professional information leaflet below is the property of Lamar International and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
